4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-036757
Chief Operating Officer sold 67,695 shares at $0.73 ($49,417)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2023-11-01 | Sale 10b5-1 | −67,695 | $0.73 | $49,417 | 310,844 | D |
| Open-market sales · 67,695 sh · avg $0.73 · $49,417 | |||||||
Loading xslF345X05/wk-form4_1699044035.xml…